• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型评分“NOD-ACLF”与其他既定预后评分对亚太肝脏研究学会慢加急性肝衰竭(APASL-ACLF)患者死亡率预测的比较:来自印度北部一家三级医疗中心的队列研究

Comparison of a Novel Score "NOD-ACLF" to Other Established Prognostic Scores for Prediction of Mortality in APASL-ACLF Patients: A Cohort Study from a Tertiary Care Center of North India.

作者信息

Patwa Ajay K, Yadav Khushboo, Atam Virendra, Usman Kauser, Sonkar Satyendra K, Chaudhary Shyam C, Kumar Vivek, Sawlani Kamal K, Gupta Kamlesh K, Patel Munna L, Reddy Dandu H, Gupta Harish, Gautam Medhavi, Kumar Satish, Kumar Amit, Yadav Ambuj, Bhagchandani Deepak, Lamba Mahak, Singh Abhishek, Mishra Ajay K

机构信息

Gastroenterology and Hepatology Unit, Department of Medicine, King George's Medical University, Lucknow, India.

Department of Medicine, King George's Medical University, Lucknow, India.

出版信息

J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101366. doi: 10.1016/j.jceh.2024.101366. Epub 2024 Feb 23.

DOI:10.1016/j.jceh.2024.101366
PMID:38495463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10940987/
Abstract

BACKGROUND

Commonly used prognostic scores for acute on-chronic liver failure (ACLF) have complex calculations. We tried to compare the simple counting of numbers and types of organ dysfunction to these scores, to predict mortality in ACLF patients.

METHODS

In this prospective cohort study, ACLF patients diagnosed on the basis of Asia Pacific Association for Study of the Liver (APASL) definition were included. Severity scores were calculated. Prognostic factors for outcome were analysed. A new score, the Number of Organ Dysfunctions in Acute-on-Chronic Liver Failure (NOD-ACLF) score was developed.

RESULTS

Among 80 ACLF patients, 74 (92.5%) were male, and 6 were female (7.5%). The mean age was 41.0±10.7 (18-70) years. Profile of acute insult was; alcohol 48 (60%), sepsis 30 (37.5%), variceal bleeding 22 (27.5%), viral 8 (10%), and drug-induced 3 (3.8%). Profiles of chronic insults were alcohol 61 (76.3%), viral 20 (25%), autoimmune 3 (3.8%), and non-alcoholic steatohepatitis 2 (2.5%). Thirty-eight (47.5%) were discharged, and 42 (52.5%) expired. The mean number of organ dysfunction (NOD-ACLF score) was ->4.5, simple organ failure count (SOFC) score was >2.5, APASL ACLF Research Consortium score was >11.5, Model for End-Stage Liver Disease-Lactate (MELD-LA) score was >21.5, and presence of cardiovascular and respiratory dysfunctions were significantly associated with mortality. NOD-ACLF and SOFC scores had the highest area under the receiver operating characteristic to predict mortality among all these.

CONCLUSION

The NOD-ACLF score is easy to calculate bedside and is a good predictor of mortality in ACLF patients performing similar or better to other scores.

摘要

背景

常用的急性慢性肝衰竭(ACLF)预后评分计算复杂。我们试图将器官功能障碍的数量和类型的简单计数与这些评分进行比较,以预测ACLF患者的死亡率。

方法

在这项前瞻性队列研究中,纳入了根据亚太肝脏研究协会(APASL)定义诊断的ACLF患者。计算严重程度评分。分析预后结局的因素。开发了一种新的评分,即急性慢性肝衰竭器官功能障碍数量(NOD-ACLF)评分。

结果

80例ACLF患者中,74例(92.5%)为男性,6例为女性(7.5%)。平均年龄为41.0±10.7(18 - 70)岁。急性损伤情况为:酒精性48例(60%),脓毒症30例(37.5%),静脉曲张出血22例(27.5%),病毒性8例(10%),药物性3例(3.8%)。慢性损伤情况为:酒精性61例(76.3%),病毒性20例(25%),自身免疫性3例(3.8%),非酒精性脂肪性肝炎2例(2.5%)。38例(47.5%)出院,42例(52.5%)死亡。器官功能障碍的平均数量(NOD-ACLF评分)>4.5,简单器官衰竭计数(SOFC)评分>2.5,APASL ACLF研究联盟评分>11.5,终末期肝病-乳酸模型(MELD-LA)评分>21.5,心血管和呼吸功能障碍的存在与死亡率显著相关。在所有这些评分中,NOD-ACLF和SOFC评分在预测死亡率方面具有最高的受试者工作特征曲线下面积。

结论

NOD-ACLF评分易于在床边计算,并且是ACLF患者死亡率的良好预测指标,其表现与其他评分相似或更好。

相似文献

1
Comparison of a Novel Score "NOD-ACLF" to Other Established Prognostic Scores for Prediction of Mortality in APASL-ACLF Patients: A Cohort Study from a Tertiary Care Center of North India.新型评分“NOD-ACLF”与其他既定预后评分对亚太肝脏研究学会慢加急性肝衰竭(APASL-ACLF)患者死亡率预测的比较:来自印度北部一家三级医疗中心的队列研究
J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101366. doi: 10.1016/j.jceh.2024.101366. Epub 2024 Feb 23.
2
[Predictive value of liver-to-spleen volume ratio for short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure].[乙肝病毒相关慢加急性肝衰竭患者肝脾体积比对于短期预后的预测价值]
Zhonghua Yi Xue Za Zhi. 2025 Jun 24;105(24):1989-1996. doi: 10.3760/cma.j.cn112137-20250222-00424.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center Study.基于人工智能的心脏CT衰减扫描检测肝脂肪变性及综合肝脏评估可增强全因死亡风险分层:一项多中心研究
medRxiv. 2025 Jun 11:2025.06.09.25329157. doi: 10.1101/2025.06.09.25329157.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Golgi protein 73 and IL-6 as strong predictors of short-term prognosis in patients with HBV-ACLF.高尔基体蛋白73和白细胞介素-6作为乙型肝炎相关慢加急性肝衰竭患者短期预后的强预测指标。
Sci Rep. 2025 Jul 1;15(1):22191. doi: 10.1038/s41598-025-06472-1.
7
Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.粒细胞集落刺激因子联合或不联合干细胞或祖细胞或生长因子输注治疗代偿期或失代偿期晚期慢性肝病患者。
Cochrane Database Syst Rev. 2023 Jun 6;6(6):CD013532. doi: 10.1002/14651858.CD013532.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
A Study of Clinical Profile and Factors Affecting Mortality in Patients With Acute-on-Chronic Liver Failure in a Tertiary Care Hospital in Nepal.尼泊尔一家三级护理医院中慢性肝衰竭急性发作患者的临床特征及影响死亡率因素的研究
Cureus. 2025 Jun 20;17(6):e86468. doi: 10.7759/cureus.86468. eCollection 2025 Jun.

本文引用的文献

1
KGHeBTA (King George's Medical University Hepatitis B Therapeutic Algorithm): A New Diagnostic and Therapeutic Algorithm and Clinico-epidemiological Spectrum of Hepatitis B.KGHeBTA(乔治国王医科大学乙肝治疗算法):一种新的乙肝诊断与治疗算法及临床流行病学谱
J Clin Exp Hepatol. 2023 Jul-Aug;13(4):629-637. doi: 10.1016/j.jceh.2023.02.007. Epub 2023 Mar 3.
2
Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Patient-Friendly Summary of the 2019 AASLD Guidelines.酒精性肝病的诊断与治疗:2019年美国肝病研究学会指南的患者友好型总结
Clin Liver Dis (Hoboken). 2021 Aug 5;17(6):418-423. doi: 10.1002/cld.1129. eCollection 2021 Jun.
3
Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF.
慢性加急性肝衰竭患者短期死亡率预后模型的比较准确性:CAP-ACLF。
Hepatol Int. 2021 Jun;15(3):753-765. doi: 10.1007/s12072-021-10175-w. Epub 2021 Jun 25.
4
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.腹水、自发性细菌性腹膜炎和肝肾综合征的诊断、评估及管理:美国肝病研究协会2021年实践指南
Hepatology. 2021 Aug;74(2):1014-1048. doi: 10.1002/hep.31884.
5
Model for End-Stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease.终末期肝病模型-乳酸与慢性肝病患者住院死亡率的预测。
Hepatology. 2020 Nov;72(5):1747-1757. doi: 10.1002/hep.31199.
6
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新:美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
7
The predictive performance of SAPS 2 and SAPS 3 in an intermediate care unit for internal medicine at a German university transplant center; A retrospective analysis.SAPS 2 和 SAPS 3 在德国大学移植中心内科中级护理单元中的预测性能;回顾性分析。
PLoS One. 2019 Sep 25;14(9):e0222164. doi: 10.1371/journal.pone.0222164. eCollection 2019.
8
Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models.肝衰竭决定慢加急性肝衰竭(ACLF)患者的结局:APASL ACLF 研究联盟(AARC)和 CLIF-SOFA 模型的比较。
Hepatol Int. 2017 Sep;11(5):461-471. doi: 10.1007/s12072-017-9816-z. Epub 2017 Aug 30.
9
A simple approximation for calculating sample sizes for comparing independent proportions.一种用于计算比较独立比例时样本量的简单近似方法。
Biometrics. 1980 Jun;36(2):343-6.
10
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.《急性-on-慢性肝衰竭:亚太肝脏研究协会(APASL)2014年共识推荐》
Hepatol Int. 2014 Oct;8(4):453-71. doi: 10.1007/s12072-014-9580-2. Epub 2014 Sep 26.